First Header Logo Second Header Logo

Connection

Joseph Rigdon to Hydroxymethylglutaryl-CoA Reductase Inhibitors

This is a "connection" page, showing publications Joseph Rigdon has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
  1. Basu S, Sussman JB, Rigdon J, Steimle L, Denton BT, Hayward RA. Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials. PLoS Med. 2017 Oct; 14(10):e1002410.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.